Programmed death 1 (PD-1) and programmed death-ligand 1 (PD-L1) are immune checkpoints, whose inhibitors have been found to trigger T lymphocytes, inhibit the growth of cancer cells, and improve survival in cancer patients (3, 4). The gene discussed is CD274; the disease is cancer.